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Abstract: Bacteriophage-encoded lysins are an emerging class of antibacterial enzymes based on
peptidoglycan degradation. The modular composition of lysins is a hallmark feature enabling
optimization of antibacterial and pharmacological properties by engineering of lysin candidates
based on lysin and non-lysin modules. In this regard, the recent introduction of the VersaTile
technique allows the rapid construction of large modular lysin libraries based on a premade repository
of building blocks. In this study, we perform a high-throughput construction and screening of
five combinatorial lysin libraries with different configurations, targeting Klebsiella pneumoniae. An
elaborate analysis of the activity distribution of 940 variants and sequencing data of 74 top hits
inhibiting the growth of Klebsiella pneumoniae could be associated with specific design rules. Specific
outer membrane permeabilizing peptides (OMPs) and enzymatically active domains (EADs) are
significantly overrepresented among the top hits, while cell wall binding domains (CBDs) are equally
represented. Especially libraries with the configuration (OMP–linker–CBD–EAD) and the inverse
configuration (CBD–EAD–linker–OMP) yield the most active variants, with discernible clusters
of variants that emerge above the remaining variants. The approach implemented here provides
a blueprint for discovery campaigns of engineered lysins starting from libraries with different
configurations and compositions.
Keywords: lysin; bacteriophage; VersaTile; Klebsiella pneumoniae; protein engineering
1. Introduction
Lysins are bacteriophage-encoded enzymes that degrade bacterial peptidoglycan.
They include virion-associated peptidoglycan hydrolases (VAPGHs) and endolysins, which
are essential in the process of phage genome injection and phage progeny release, respec-
tively [1]. Based on their clinical impact and technical feasibility, they are regarded as
one of the alternative classes with high potential as antimicrobial therapeutics for clinical
practice [2]. This auspicious ability as potential therapeutics is attributable to a number of
beneficial and unique properties associated with this class of antibacterials. First, lysins
have a rapid mode-of-action based on enzymatic activity acting immediately upon contact.
This active mechanism also enables the killing of persister cells [3]. Secondly, they possess
a narrow-spectrum activity, hereby limiting the impact on the natural microbiome, in
contrast to conventional broad-spectrum antibiotics. Thirdly, the development of bacterial
resistance by the accumulation of point mutations is generally not observed for lysins [4].
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In addition, initial concerns about the proteinaceous nature of lysins appear to be refuted.
An antibody response is elicited but does not impede the in vivo activity, likely due to
the rapid action of lysins. Also, allergic responses or other side effects are not reported in
animals or clinical trials [1].
Apart from these properties, lysins differentiate from all other antibacterial classes in
their modular composition and the associated opportunities to modulate the antibacterial
properties. This modularity implies that lysins are composed of contiguous domains with
distinct, dedicated functions, each affecting the antibacterial activity. These domains can
be either a CBD or an EAD. Lysins can be engineered through recombining or swapping
these domains from various sources to enhance their activity, solubility, stability, or speci-
ficity [1,5]. Moreover, the addition of non-lysin modules such as OMPs to transfer the
lysin moiety through the otherwise lysin-impermeable outer membrane of Gram-negative
bacteria (commercialized as Artilysin®) [6], cell-penetrating peptides to enter a eukaryotic
cell [7], or an albumin-binding domain to increase the half-life of a lysin in blood, further
expand the customization possibilities of lysins [8]. In this regard, libraries of increasing
sizes are being screened to identify variants with the desired properties. Briers et al. (2014)
constructed a library of 49 Artilysins with different configurations and evaluated the ef-
fect on the antibacterial activity against Pseudomonas aeruginosa, Acinetobacter baumannii,
Escherichia coli, and Salmonella enterica serovar Typhimurium [6]. Hang et al. (2017) screened
a library of 126 engineered lysins to identify active variants against planktonic and biofilm
methicillin-resistant Staphylococcus aureus [9]. Further, Verbree et al. (2017) and Röhrig et al.
(2020) screened a library of 174 and 322 variants of engineered lysins and other recombi-
nant peptidoglycan hydrolases for activity against Staphylococcus aureus under raw milk
and intracellular conditions, respectively [7,10]. These libraries of modular or truncated
variants were all constructed with traditional restriction/ligation techniques, which are
time-consuming and labor-intensive. To eliminate this technical hurdle, we have recently
introduced a rapid DNA assembly method for an efficient combinatorial assembly of lysin
domains, coined “the VersaTile technique”. With this approach, large libraries of combina-
torically shuffled lysins comprising up to thousands or millions of variants can be created
rapidly, starting from a practically infinite number of non-homologous domains [5].
Gerstmans et al. (2020) generated a library of around 10,000 shuffled lysins with the
VersaTile technique and selected a variant with high inhibitory activity against the Gram-
negative critical priority pathogen Acinetobacter baumannii under human serum conditions.
To achieve this goal, they implemented iterative rounds in which repeatedly smaller
and enriched libraries were created and tested, depending on the observed structure–
activity relationships. Based on prior knowledge, they focused on a single configuration
(OMP–linker–CBD–EAD) [5]. A linker was introduced to grant sufficient autonomy and
flexibility to the OMP and CBD-EAD moieties. In this study, we applied VersaTile to
establish a pairwise comparison of the influence of the modular configurations on the
growth inhibitory activity of engineered lysins against Klebsiella pneumoniae. Four new
configurations were generated and screened along with the previous configuration. In total,
over 444,000 variants were constructed with the VersaTile technique, of which 940 variants
could be screened using plate-based growth inhibitory assays.
We selected Klebsiella pneumoniae as a target species, an important ESKAPE pathogen
(Enterococcus faecium, S. aureus, K. pneumoniae, A. baumannii, Pseudomonas aeruginosa and
Enterobacter species). This pathogen ranks among the most urgent and serious threats
for our healthcare system [11], as they have developed increased levels of resistance to
commonly used antibiotics as well as last resort antibiotics. Indeed, K. pneumoniae strains
producing extended-spectrum beta-lactamases (ESBLs) are increasingly prevalent or have
evolved to carbapenem-resistant Enterobacteriaceae (CRE) [12].
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2. Results
2.1. The Construction of Five Libraries with Different Configurations Using VersaTile
The VersaTile technique entails two steps. First, a repository of building blocks
(called tiles) needs to be constructed. A tile comprises the coding sequence and is flanked
by position tags, labeling its position in the final assembly. Second, these tiles can be
recombined in either a rational or combinatorial way. In a four-way system, at least one
tile needs to be added for each of the four positions. Gerstmans et al. (2020) prepared
a repository of 67 tiles in total (38 OMPs, 2 linkers, 6 CBDs, and 21 EADs at position 1,
2, 3, and 4, respectively) for the construction of a library with an OMP-linker-CBD-EAD
configuration [5]. In this work, we constructed libraries with four additional configurations
by repositioning the same defined modules and/or doubling the OMP module (Figure 1).
As such, the impact of the configuration on the antibacterial activity can be assessed and
specific design rules can be deduced.
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Figure 1. The different configurations tested in this study. Configuration 1 is the configuration
analyzed in previous work [5]. OMP: outer membrane permeabilizing peptide, CBD: cell wall binding
domain, EAD: enzymatically active domain. The total number of available tiles for configurations 1
through 5 are mentioned under each specific position. The resulting possible variants are indicated
within the brackets.
All configurations were derived from the previously analyzed configuration 1 (OMP–
linker–CBD–EAD). First, the combination CBD–EAD is retained in all configurations
since this order mainly occurs in natural modular lysins produced by bacteriophages
infecting Gram-negatives [6]. Next, the position of the OMP was altered. A single OMP
was placed either at the N-terminal position (configuration 1) or the C-terminal position
(configuration 4). Double OMPs were placed either at the N-terminus (configuration 3), at
the C-terminus (configuration 5), or one at both sides (N- and C-terminus, configuration 2).
In the case of a single OMP, a linker was included to specifically separate the OMP from the
CBD–EAD domain, while conveniently retaining the four-way assembly setup present in
the other configurations. To construct libraries with these four new configurations, the tile
repository from our previous study was further expanded with additional tiles: (1) Tiles
with the same coding sequences but different position tags; (2) Tiles with additional coding
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sequences for four OMPs, five linkers and two EADs with position tags for their respective
positions. The previous repository only comprised two linker tiles encoding highly flexible
linkers forming a coil solely consisting of small flexible amino acids (glycine and alanine).
Therefore, additional linkers with a rigid structure were generated and included. This rigid
structure can be achieved either through a helix or a proline-rich coil [13]. As such, the
influence of the linker structure on the activity could also be evaluated. The total number
of tiles was 218 (Figure 1; Supplementary Materials Table S2). A detailed description of
each tile is given in Table S3. Note that the repository was partially asymmetric with not
all coding sequences at each position. However, a minimum identical set of 27 OMPs, six
linkers, four CBDs, and 12 EADs was available for each relevant position.
Based on the available repository, a combinatorial assembly reaction was performed
for each configuration. The resulting complexities (Figure 1) are 40,572 (Configuration 1;
42 × 7 × 6 × 23), 202,860 (Configuration 2; 42 × 6 × 23 × 35), 156,492 (Configuration 3;
42 × 27 × 6 × 23), 10,080 (Configuration 4; 4 × 12 × 6 × 35), and 45,360 (Configuration 5;
4 × 12 × 27 × 35). This illustrates the high-throughput capacity of the VersaTile reaction.
Previous deep sequencing experiments using Nanopore technology demonstrated equal
incorporation of the variable tiles in the library variants [5,14].
2.2. The Hit Rate of the Libraries Depends on the Configuration of the Engineered Lysins
To evaluate and to compare the antibacterial activities of the variants from the different
libraries, 188 variants were randomly selected from each configuration and expressed,
followed by the preparation of cleared lysates. These cleared lysates were evaluated for
their growth inhibitory activity against K. pneumoniae ATCC 13,833 both in the absence
and the presence of 0.5 mM EDTA. EDTA chelates the divalent cations Ca2+ and Mg2+
and destabilizes the outer membrane since these cations are essential for outer membrane
stability by bridging the phosphate groups of adjacent lipopolysaccharide molecules [15].
As such, EDTA may enhance the antibacterial activity [16] and may lower the detection
limit of the assay, resulting in a higher number of hits. To compare the antibacterial
activity and protein yield of the evaluated variants, we converted all values to growth
inhibition percentages. A higher growth inhibitory percentage corresponds to a higher
growth inhibitory activity.
Figure 2 shows the distribution of the growth inhibition percentages of the analyzed
variants per configuration, in the absence (Figure 2a) or the presence (Figure 2b) of 0.5 mM
EDTA. Two phenomena can be distinguished in the distribution of the activities. First,
in the case of the best configurations (1 and 4), we see discernible top clusters of highly
active variants and more stretched clusters of semi-active variants. Configuration 1 has the
largest top cluster and represents as such the most successful combination of the available
building blocks. The bulk of variants of configuration 2 and especially configuration 5 are
chiefly grouped at the bottom with no inhibitory effect. However, they both show a long
tail of variants with rising activity with a small differentiated top cluster. Configuration 3
shows a more equal distribution of active variants, but only up to a maximal inhibitory
value of approximately 60%. Based on these findings, we will consider variants that inhibit
the bacterial growth for more than 80% as hits.
When we look in more detail, we can state that screening four of five configurations
resulted in numerous hits. Configuration 1 (OMP–linker–CBD–EAD) and configuration 4
(CBD–EAD–linker–OMP), which have a mirrored composition, have the highest hit rate
(without EDTA: 38.3% and 18.6%, with EDTA: 50.5% and 12.8%, respectively). The hit
rate for configuration 2 (OMP–CBD–EAD–OMP; without EDTA: 11.7%, with EDTA: 2.7%)
and configuration 5 (CBD–EAD–OMP–OMP; without EDTA: 3.7%, with EDTA: 5.3%) is
considerably lower, and all hits behave as outliers compared to the bulk of the variants.
Notably, variants from configuration 3 that start with a double OMP (OMP–OMP–CBD–
EAD) are active but do not inhibit the bacterial growth for more than 80% (hit rate of
0%). Beyond these differences in hit rate, EDTA has a positive impact on the antibacterial
activity of all configurations except configuration 2. EDTA increases the growth inhibition
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percentage for these configurations by 12.9%, on average. In particular, EDTA has the most
positive influence on the most performant configuration (configuration 1, +22%) and has
the least effect on the antibacterial activity of the variants of configuration 5 (+1%).
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2.3. Sequencing of the Most Active Hits Gives Design Rules
By sequencing the most active variants, insights are obtained on which tiles contribute
the most to the growth inhibitory activity. This enables us to define structure–activity
relationships, which in turn can serve as a starting point for improving or developing
new libraries. Here, we sequenced the hits of the top clusters of the two most active
configurations (configuration 1 and 4), specifically those hits with a growth inhibition
percentage above 95%. For configuration 1, 53 different sequences were analyzed (Table S4),
of which 33 reach a growth inhibition of 95% in the absence of EDTA and 36 reach 95% in
the presence of EDTA. When variants inhibit more than 95% only in the absence of EDTA,
the range of inhibition in the presence of EDTA is between 24–94%, whereas for variants
that inhibit more than 95% only in the presence of EDTA, the range of inhibition in the
absence of EDTA is between 0–91% (Figure S1). In the case of configuration 4, 21 different
sequences were analyzed (Table S5), of which 12 and 15 reach a growth inhibition of 95%
in the absence of and presence EDTA, respectively. When variants inhibit ore than 95
only in the absence of E T , the range of inhibition in the presence of E T is bet een
38–94 , hereas for variants that inhibit more than 95% only in the presence of EDTA, the
range of inhibition in the absence of EDTA is between 15–93% (Figure S2).
iff r t istri ti s r siti t rr s f t iff r t til s t
i iti t t ll lti i l i t i ti t
fi .
istribution of OMPs deviates ignificantly from a uniform distribution (p < 0.1) for
both configurations, both in the absenc or the presenc of EDTA (Table 1). Additionally
for configuration 1, we se a significantly deviating distr bution for EADs, regardless of
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the presence of EDTA, whereas, for configuration 4, this is also the case for the linkers in
the presence of EDTA.
Table 1. p-values calculated for the different distributions per position, both when EDTA is absent and present in the
antibacterial assay. An asterisk indicates a significantly different distribution compared to a uniform distribution.
Configuration Position Type Building Block p-Value (no EDTA) p-Value (EDTA)
1 1 OMP 0.00035 * 0.0074 *
1 2 Linker 1 1
1 3 CBD 1 1
1 4 EAD 0.021 * 0.047 *
4 1 CBD 1 1
4 2 EAD 0.19677 0.39673
4 3 Linker 0.68365 0.04107 *
4 4 OMP 0.01894 * 0.00001 *
Therefore, we analyze the occurrences of the different, significantly deviating tile
types. The overrepresented tiles are listed per position in Table 2.
Table 2. Statistical analysis of overrepresented tiles. All significantly overrepresented tile types (Bonferroni correction, p <
0.1/42 (=0.0024) and p < 0.1/35 (=0.0029) for OMPs of configuration 1 and 4, respectively; p < 0.1/23 (=0.0043) for EADs
of configuration 1; and p < 0.1/6 (=0.017) for the linker of configuration 4, with α =0.1) for a single or both conditions
(without/with EDTA), are shown along with their number of occurrences and p-values. N◦ is the number of occurrences in
the sequenced hits. The total numbers of sequenced hits per subgroup are as follows: N◦ (configuration 1, without EDTA) =
max. 33, N◦ (configuration 1, with EDTA) = max. 36, N◦ (configuration 4, without EDTA) = max. 12, and N◦ (configuration
4, with EDTA) = max. 15. NS = not significant.
Configuration Type Building Block Tile
Without EDTA With EDTA
N◦ p-Value N◦ p-Value
1 OMP Protegrin (OMP3) 7 8.4 × 10−7 10 4.8 × 10−10
1 OMP Chrysophsin-1 (OMP20) 4 0.0010 3 NS (>0.0024)
1 EAD 201φ2-1gp229-EAD (EAD12) 5 0.0027 4 NS (>0.0043)
1 EAD KZgp181 (EAD19) 3 NS (>0.0043) 7 0.00013
4 OMP Cathelicidin-BF antimicrobial peptide (OMP35) 5 2.2 × 10−7 5 4.3 × 10−6
4 Linker Rigid long helix (Linker 4) 4 NS (>0.017) 5 0.0080
The most common peptide in the first configuration on position 1 is OMP3 or Protegrin.
This peptide is significantly overrepresented either with or without the addition of EDTA.
More specifically, it is present in 21% (7/33) of all hits without EDTA and in 28% (10/36)
hits in the presence of EDTA. Since the theoretical occurrence in the library is about 2.4%,
this corresponds to a roughly tenfold overrepresentation. However, this peptide is not
detected in the top hits of configuration 4 on position 4, where OMP5 or the Cathelicidin-BF
antimicrobial peptide is most present. It is represented in 42% (5/12) in the hits without
EDTA and 33% (5/15) in hits with EDTA, which is 20-fold more than the theoretical
occurrence of 2.9% (1/35). This implies that tile overrepresentation is position-dependent
in the configuration of the lysins.
Besides OMP3, OMP20 or Chrysophsin-1 also shows a significant positive influence
on the antibacterial activity in the absence of EDTA, when assembled on position 1 of
configuration 1. Here, it is represented in 12% (4/33) of the hits, which corresponds to a
roughly 5-fold overrepresentation. Notably, both peptides do not show similar properties.
At the fourth position of configuration 1, EAD12 or the EAD of the modular 201φ2-
1gp229 endolysin [16] is significantly overrepresented in the absence of EDTA, while EAD19
of the structural lysin of phage φKZ (KZgp181) [17] is significantly overrepresented in the
hits identified in the presence of EDTA. Since the theoretical occurrence in the library for
the EADs was about 4.3% (1/23), these tiles are almost 3.5 to 4.5-fold overrepresented (15%
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(5/33) and 19% (7/36), respectively). However, these EADs were not available on position
2 in the tile repository and were thus not evaluated in configuration 4.
At the third position of configuration 4, we see a 2-fold overrepresentation of the
rigid long linker with a helical structure (Linker 4) (33%, 5/15) in the presence of EDTA,
compared to its theoretical occurrence of 17% (1/6).
We also analyzed whether variants with a flexible linker perform significantly better
or worse than variants with a rigid linker, but no difference was observed (No EDTA:
p = 0.186 (configuration 1) and p = 0.122 (configuration 4), EDTA: p = 0.225 (configuration 1)
and p = 0.301 (configuration 4)).
3. Discussion
VersaTile is a high-throughput DNA assembly method that enables the creation of a
practically infinite number of shuffled and engineered lysins, starting from a repository
comprising distinct building blocks, called tiles. A major advantage of this technique is
the possibility to easily and quickly expand these repositories with new tiles and add to
the availability of previously constructed tiles. Moreover, VersaTile addresses the need
of continuously evolving research questions and the investigation of new design rules
for these antibacterial enzymes. In this study, the total number of tested variants was
increased by almost 2-fold in comparison with the highest number in previously published
studies (940 versus 568 [5]). Nevertheless, this number of screened variants still represents
low percentages of the whole libraries, with complexities ranging from 10,080 variants
(188/10,080 = 1.87%) to 202,860 variants (188/202,860 = 0.0927%), highlighting the need
for techniques that allow more representative high-throughput screenings. Although
the screened variants are a randomly selected subset of the libraries, this subset gives
an insightful snapshot of the different configurations. It turned out that the previously
analyzed configuration is the configuration that yields the most active variants against
K. pneumoniae ATCC 13883. Configuration 4 (the opposite combination) shows a smaller
group of active variants as well. However, when implementing two peptides in the
configuration (2, 3 and 5), we observe a strongly reduced number of active variants,
especially when two OMPs are located at the N-terminus (configuration 3). A possible
explanation for the inferior performance of the configurations with two peptides might
be a reduced protein expression or inferior folding, especially in the case of random coils
having little structure. Alternatively, double OMPs may result in an increased formation of
aggregates due to the hydrophobic nature of some peptides, resulting in a smaller portion
of active protein. Conversely, the higher activity of configuration 1 and 4 could be a result
of the introduction of a linker between the OMP and the CBD–EAD moiety. This linker may
grant more autonomy to both parts that must operate successively during the antibacterial
action by introducing a physical separation. The lack of a linker in configuration 2, 3, and 5
may consequently inhibit this sequential action and autonomy of both moieties. Flexible
linkers provide the lysins with a certain degree of conformational mobility between the
functional domains, whereas rigid linkers rather fix the distance and relative orientation.
It has also been reported that flexible linkers cause certain limitations, such as a poor
protein expression or a reduction in biological activity. Rigid linkers are more appropriate
to conserve the autonomous functions of the domains due to a more effective, physical
separation [13]. Therefore, rigid linkers might improve the activity more than flexible
linkers. However, in this study, we did not observe a significant overrepresentation of the
rigid linkers compared to the flexible linkers. Hits were observed either without EDTA,
with EDTA or in both conditions. This may imply that the variants are operating by
different working mechanisms. Some may independently break through the OM locally
by displacing the divalent ions from their binding site on the LPS, whereas others require
EDTA to perform this action. The latter variants may have good characteristics to pass
through the hydrophobic part (lipid A moiety and phospholipids) of the OM. In previous
studies, EDTA significantly improved the antibacterial activity of lysins against P. aeruginosa
and A. baumannii. However, when targeting the Enterobacteriaceae members E. coli and
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S. enterica serovar Typhimurium, this effect was not clearly observed [3,6]. Also in this
study, we only observed a limited effect of EDTA against the Enterobacteriaceae member
K. pneumoniae. The difference in affecting the antibacterial activity may be related to the
differences of the outer membrane structures of these bacteria. The phosphate-rich outer
membrane of P. aeruginosa and A. baumannii correlates with a higher amount of divalent
cations such as Mg2+ and Ca2+ that bridges adjacent LPS molecules and stabilizes the
outer membrane. Enterobacteriaceae contain a lower phosphate content, but instead, the
stabilization occurs through hydrophobic interactions between the longer acyl chains of
the lipid A moiety [18]. It should be noted that EDTA cannot be used for systemic use
because of its anticoagulant properties [19] and was mainly evaluated here to improve the
sensitivity of the assay.
We have shown here that the VersaTile technique allows to set up quick screenings of
an unprecedented number of variants, by eliminating the hurdle of library construction.
However, this brings up new challenges in library screening as a practically infinite number
of choices can be made at this stage. The first law of directed evolution states ‘you get what
you screen for’ [20]. Therefore, the choice of an assay, screening conditions and test species
affect the eventual outcome. Röhrig et al. [7] demonstrated a high inter-assay variability,
comparing time-kill, turbidity reduction, and spot on the lawn assays under extracellular
and intracellular conditions. The authors mediated these biases by performing multiple
assays and integrating all outputs in a weighted score. The challenge is thus to define
robust and relevant in vitro proxy assays for the envisioned in vivo applications. The
screening conditions can be either general as performed in this study or can be tailored
to the conditions prevailing in the natural infection habitat of Klebsiella species, such
as human serum, urine, and lung fluid. The same screening assays can be performed
using artificial media that mimic the actual growth conditions such as synthetic urine or
synthetic lung fluid. The inclusion of several strains having different bacterial capsules
and LPS compositions will also strengthen the robustness of the extracted design rules.
Such multiparametric screening campaigns require extensive efforts and are facilitated by
dedicated equipment such as an automated liquid handler.
The screening was performed using cleared lysates instead of purified proteins to
enable dealing with a large number of variants (as well as reduce cost). This implies that
the screening outcome is influenced by the expression yield, protein solubility and growth
inhibitory activity per mole. While screening with cleared lysates is a standard approach
in protein engineering, this hinders the separate evaluation of these factors. Yet, from
the perspective of downstream applications, the combination of a high production yield
of soluble protein with high antibacterial activity is the most desired outcome and these
variants will eventually prevail in the followed screening setup. Indeed, in our previous
study, the lead molecule selected after three iterative screenings combined a high expression
yield and antibacterial activity [5]. The current screening setup and stringency also resulted
in a clear differentiation of variants between and within the configurations, indicating a
good resolving power to rank configurations and variants and to learn design rules.
4. Materials and Methods
4.1. Bacterial Strains and Growth Media
For the storage of the plasmids necessary for the VersaTile reaction, Escherichia coli
TOP10 cells were chosen, whereas for the expression of the proteins, we used E. coli BL21-
CodonPlus(DE3)-RIL cells (Agilent Technologies, Belgium). Both strains were grown either
in Lysogeny Broth (LB) (1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl)
and shaking at 180 rpm and 37 ◦C, or on LB agar (addition of 1.5% (w/v) bacteriological
agar) at 37 ◦C. For small-scale expression of the lysin variants, E. coli cells were grown
in auto-induction medium. This medium consists of a combination of ZY medium, 2 M
MgSO4, 50× 5052-solution, and 20× NPS [16]. To select for plasmid-containing E. coli cells,
media were supplemented with either 100 µg/mL ampicillin or 50 µg/mL kanamycin, and
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5% (w/v) sucrose. For the high-throughput antibacterial assay, Klebsiella pneumoniae strain
ATCC 13883 was grown in Mueller Hinton (MH) broth.
4.2. Expanding of Tile Repository: VersaTile Cloning
The previously reported tile repository [5] was expanded with new tiles and tiles
with altered positions. The construction of new tiles (linkers) in this study was performed
by hybridization of partially overlapping primer cassettes (Table S1; Integrated DNA
Technologies, Leuven, Belgium). To alter the positions of existing tiles, a PCR amplification
with tailed primers was performed using previously made tiles (in their entry vectors)
as a template. The tailed primers consisted of three parts. The 5′ end contained a SapI
recognition and restriction site for cloning in the entry vector pVTE (VersaTile cloning).
Next, a BsaI recognition and restriction site within an appropriate position marker was
included for the assembly of the four building blocks (VersaTile shuffling). Last, a sequence
complementary to the coding sequence of the respective tile was placed at the 3′ end of
the primer.
PCR amplification of the new tiles was performed using Pfu DNA polymerase (1.25 U)
according to the manufacturer’s guidelines. For the hybridization of the primer cassettes,
a fill-in reaction was needed. First, an equal ratio of the primers (10 µM) was mixed and
incubated for 2 min at 95 ◦C. Next, to form dimers, the reaction was gradually cooled down
until room temperature. Subsequently, the fill-in reaction of the single overhanging strands
was performed using Pfu DNA polymerase (1.25 U, 10 min at 72 ◦C).
The reaction mixture for the simultaneous restriction and ligation of the amplified
fragments and the filled-in primer cassettes in the entry vector pVTE3, contained 2 µL
T4 DNA ligase buffer, 3 U T4 DNA ligase, 100 ng pVTE3, 50 ng of the amplicon/primer
cassette, and 10 U SapI, to a total volume of 20 µL. After ligation, the mixture was used for
transformation of chemically competent E. coli TOP10 cells, followed by selection on LB
1.5% agar with 100 µg/mL ampicillin and 5% (w/v) sucrose. Last, the tile entry vectors were
isolated by plasmid extraction and the sequence was confirmed using Sanger sequencing
(LGC Genomics, Berlin, Germany). The correct tiles were each diluted to 46 nM and stored
in our repository.
4.3. Construction of Libraries: VersaTile Shuffling
Before performing the assembly reaction, all the OMPs, linkers, CBDs, and EADs per
specific position were grouped, each in one tube per specific building block, by combining
1 µL of each tile (46 nM). The shuffling reaction comprised 1 µL of 25 nM pVTD2 (as
destination vector), 1 µL of each tile mixture (on the required position), 10 U BsaI (as
restriction enzyme), 3 U of T4 DNA ligase, and 2 µL of T4 DNA ligation buffer, with a
total reaction volume of 20 µL. The VersaTile shuffling reaction mixture was incubated
during 50 cycles of 2 min at 37 ◦C (restriction) and 3 min at 16 ◦C (ligation), followed
by one cycle of 5 min at 50 ◦C (ligase inactivation) and one cycle of 5 min at 80 ◦C (BsaI
inactivation). Afterwards, the entire reaction mixture was used for transformation of
chemical competent BL21-CodonPlus(DE3)-RIL cells, followed by plating onto LB 1.5%
agar plates, supplemented with 50 µg/mL kanamycin and 5% (w/v) sucrose.
4.4. High-Throughput Growth Inhibitory Assay
First, single colonies from the plated E. coli BL21-CodonPlus(DE3)-RIL cells from the
VersaTile shuffling transformations were inoculated in a 96-deep well plate, filled with
500 µL LB supplemented with 50 µg/mL kanamycin in each well. The plate was incubated
overnight (18 h) in a microtiter plate shaker (VWR) at 37 ◦C and 900 rpm, covered with
tape allowing air exchange. The next day, the overnight culture was used to inoculate a
new 96-deep well plate filled with 500 µL auto-induction medium and incubated for 5 h
at 37 ◦C and 900 rpm in a microtiter plate shaker (VWR). Thereafter, the temperature was
changed to 16 ◦C for 43 h. Following expression, the 96-deep well plate was centrifuged
at 3200× g and 4 ◦C for 30 min, and the resulting supernatants are discarded. To release
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the recombinant lysin fusion proteins, cells were lysed by placing the deep-well plate over
a chloroform-saturated filter, soaked in 80 mL chloroform, for 2 h, followed by 15 min
evaporation of the residual chloroform. The obtained lysates in each well were suspended
in 500 µL HEPES-NaOH, pH 7.4, and 1 U DNase I, followed by 1 h shaking at 700 rpm and
room temperature to ensure complete resuspension. To confirm complete lysis, 5 µL of each
well was spotted on an LB 1.5% agar plate and incubated overnight at 37 ◦C. The 96-deep
well plate with lysates was centrifuged again to separate the soluble and insoluble fraction.
The Klebsiella test strain was prepared in MH broth and incubated overnight at 37 ◦C.
Subsequently, the culture was diluted in 2× MH to an OD625nm of 0.08–0.1 (DeNovix®
DS-11 Spectrophotometer, Denovix Inc., Wilmington, NC, USA), followed by a 100-fold
dilution. When mentioned, a final concentration of 1.0 mM EDTA-Na2 was added to the
100-fold diluted Klebsiella cell suspension. From this solution, 50 µL (5 × 106 cells/mL) was
added to each well of a microtiter plate together with 50 µL of the lysin variants, resulting
in a 0.5 mM EDTA-Na2 concentration. The respective microtiter plates were incubated for
20 h at 37 ◦C. Finally, the growth inhibitory activity was determined using an endpoint
measurement at 655 nm and the optical densities were converted to growth inhibition
percentages. This parameter indicates the degree to which the bacterial growth is inhibited
and is calculated with the following formula:
Growth inhibition (%) = ((1 − (ODvariant − ODblank))/(ODnegative control − ODblank)) × 100, (1)
with ODvariant, ODblank and ODnegative control corresponding to the optical density at 655 nm
after 20 h for the variant, the medium, and the untreated cells respectively. Eventually, plas-
mids were extracted from top hits (>95%) of configuration 1 and 4, and the corresponding
lysin sequences were analyzed using Sanger sequencing (LGC Genomics, Germany).
4.5. Statistics
For statistical analysis, we assumed a null hypothesis where, within every type of
building block, every tile has an equal chance of occurring in an active design. This means
that the probability of observing a tile is equal to one over the number of possible tiles for
that position. To test whether a building block deviates from this uniform occurrence null
hypothesis, we used a multinomial null distribution with uniform event probabilities to
model the occurrence of tiles in an architecture. Our test statistic was the number of different
tiles observed in the active design. We computed the p-value by taking 100,000 samples
from the null distribution and counting the fraction that has fewer distinct tiles than
in our observations. To test for significance of individual tiles within a position, we
used a similar setup. The p-values were computed based on the implied binomial null
distribution, i.e., the probability of seeing as many or more of the tiles in the active designs,
given equal probabilities of occurrence. The corresponding p-values were compared to
a significance level (α) of 0.1. Bonferroni correction was taken into consideration when
multiple comparisons were performed (42 possible OMPs and 23 possible EADs at position
1 and 4 of configuration 1, and 6 possible linkers and 35 possible OMPs at position 3 and 4
of configuration 4, respectively). This was specifically applied in the case of the multiple
dependent statistical test of the occurrences of the tiles per position [14].
To analyze if the occurrences of the flexible and rigid linkers after the screening differ
significantly, a Chi-Square test was performed, using IBM® SPSS® Statistics software (IBM
Corporation, New York, NY, USA, Version 26). The p-values are compared to a significance
level (α) of 0.1 as well.
Supplementary Materials: The following are available online at https://www.mdpi.com/2079-638
2/10/3/293/s1, Figure S1: Growth inhibition percentages of selected hits of configuration 1, Figure
S2: Growth inhibition percentages of selected hits of configuration 4. Table S1: Primers designed for
the construction of new linker tiles, Table S2: The total number of tiles per type of building block and
per possible position, Table S3: Detailed description of each tile, Table S4: A list of the sequenced
active constructs, supplemented with the sequences and numbers of their separate tiles and the
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growth inhibition percentages in absence and presence of EDTA. Table S5: A list of the sequenced
active constructs of configuration 4, supplemented with the sequences and numbers of their separate
tiles and the growth inhibition percentages in absence and presence of EDTA.
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